McDermott and Bull executive Search

Other News

Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.

Agreement expands company’s access to pulsed field ablation technology MARLBOROUGH, Mass., Sept. 21, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation […]

ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19

WESTMINSTER, Colo., Sept. 21, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) under the Coronavirus Treatment Acceleration Program (CTAP) to evaluate AB201 […]

BIOLIFE4D Names Pharmaceutical Veteran Kate Lewis as President

Company’s first female executive to lead commercialization efforts of BIOLIFE4D’s live-saving 3D bioprinting technologies CHICAGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Kate Lewis as President of the company. She […]

AngioDynamics Announces Commercial Launch of Auryon Atherectomy System in United States

ADVANCED MEDICAL TECHNOLOGY SAFELY1 & EFFECTIVELY TREATS PAD, CLI, ISR LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the Auryon Atherectomy System, a newly-developed innovative technology for the treatment of Peripheral […]

CardieX Granted Patent in Europe for Key Brachial Cuff Blood Pressure Technology

IRVINE, Calif., Sept. 18, 2020 /PRNewswire/ — CardieX Limited (ASX: CDX) (CardieX, the Company) announced today that CardieX subsidiary ATCOR was granted a new patent by the European Patent Office (EPO) for the Company’s proprietary SphygmoCor® technology used in cuff-based blood pressure devices. EPO Patent Number EP2566387 further protects the company’s intellectual property in […]

Prytime Medical™ Launches New ER-REBOA™ PLUS Catheter

REBOA refined. REBOA made easier. SAN ANTONIO–(BUSINESS WIRE)–Prytime Medical Devices, Inc. introduced its latest aortic occlusion catheter, the ER-REBOA™ PLUS this week at the American Association for the Surgery of Trauma (AAST) Annual Meeting. Designed for improved ease of use, it is REBOA refined for controlling massive non-compressible hemorrhage. “The […]

Compelling New Research Links Increased Omega-3 Intake to Improved Cardiovascular Outcomes

Study published in Mayo Clinic Proceedings supports multiple cardiovascular risk reductions SALT LAKE CITY, Sept. 17, 2020 /PRNewswire/ — A new study, the most comprehensive analysis of the role of omega-3 dosage on cardiovascular prevention to date, provides compelling evidence for consuming more EPA and DHA (eicosapentaenoic acid and docosahexaenoic acid, respectively) […]

Medtronic TYRX™ Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections

Economic Analysis of the WRAP-IT Patient Population in Circulation: Arrhythmia and Electrophysiology Long-Term Results from WRAP-IT, Data on Impact of Infections Also Published DUBLIN, Sept. 16, 2020 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study, showing the TYRX™ Absorbable Antibacterial Envelope […]

Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US

Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on social injustice Commitment to include partnerships and support to address the underrepresentation of minorities, including African American/Black and Hispanic communities, in clinical trials Reinforces US […]